Literature DB >> 20043703

Telehealth tools for public health, emergency, or disaster preparedness and response: a summary report.

Dale C Alverson1, Karen Edison, Larry Flournoy, Brenda Korte, Charles Magruder, Craig Miller.   

Abstract

Rapid advances in telehealth development and adoption are increasing the spectrum of information and communication technologies that can be applied not only to individual patient care but more broadly to population health as well. Participants in this breakout session were asked to address, from their diverse perspectives, a series of questions relating to the current and potential uses of telehealth applications and networks for public health and emergency/disaster preparedness and response systems. Participants identified several gaps in current understanding and research emphasis. There is a clear need for more and larger outcome studies to assess the impact and cost benefit of telehealth applications in terms of improving public health at the population and community levels. In addition, more research is needed to demonstrate the ability of telehealth tools and technologies to facilitate and extend the reach of major national clinical and public health research initiatives. Perhaps most importantly, the National Institutes of Health should develop and/or strengthen strategic partnerships with other funding agencies with overlapping or complementary interests to accelerate interdisciplinary research in this rapidly evolving but relatively understudied and complex field.

Entities:  

Mesh:

Year:  2010        PMID: 20043703     DOI: 10.1089/tmj.2009.0149

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  2 in total

1.  Telemedicine and e-health in disaster response.

Authors:  Charles R Doarn; Ronald C Merrell
Journal:  Telemed J E Health       Date:  2014-06-11       Impact factor: 3.536

Review 2.  Telemedicine: Pediatric Applications.

Authors:  Bryan L Burke; R W Hall
Journal:  Pediatrics       Date:  2015-07       Impact factor: 7.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.